As part of the settlement, Endo will pay $10 million and donate $1 million worth of diabetes and allergy drugs to two Ohio counties that were chosen to serve as bellwethers in litigation over the opioid epidemic.
Endo still faces similar lawsuits from hundreds of other cities, counties and states.
The landmark October trial will still proceed against other drugmakers and distributors, including Purdue Pharma, Teva Pharmaceuticals, Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen. It is the first trial in the U.S. that seeks to hold drugmakers and distributors liable for opioid addiction and overdoses.
The companies named as defendants have denied allegations that their marketing and distribution practices fueled the opioid crisis in the U.S.
More articles on opioids:
Florida, Military Health System to share PDMP data
The challenges of lowering opioid prescriptions
More than half of privately insured kids getting tonsils removed receive opioids
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
